podcast

Sales & Marketing

Pharma’s post-COVID prospects: the pharmaphorum podcast

In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season.

Market Access

Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaph...

Episode 35 of the pharmaphorum podcast hears from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit. With RNA-based technology hitti

R&D

Big data and cell therapy development: the pharmaphorum podc...

In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who's the CEO of Mogrify.

R&D

GSK on COVID and vaccine development: the pharmaphorum podca...

In the latest episode of the pharmaphorum podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandem

Digital

The meaning of digital innovation: the pharmaphorum podcast

This instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, and features digital transformation leader Edwin Erckens.

R&D